The current study shows the impressive clinical heterogeneity of LFS, highlights particularities of the founder TP53 pathogenic variant R337H and points to the need for larger and collaborative studies to better define LFS prevalence, clinical spectrum and penetrance of different types of PVs in the Brazilian population. Here, TP53 is linked to Li-Fraumeni syndrome.